keyword
https://read.qxmd.com/read/38605700/outcome-of-lung-transplantation-in-patients-with-pulmonary-alveolar-microlithiasis-in-the-era-of-covid-19-infection
#1
Lekhya Raavi, Pankaj Garg, Mohammad Alomari, Nafiye B Celik, Ian A Makey, Mathew Thomas, Aziza Nassar, Basar Sareyyupoglu, Samuel Jacob, Si M Pham, Magdy M El-Sayed Ahmed
Lung transplant recipients are at higher risk of developing COVID-19 infection compared to other solid organ transplants. The risk further increases in the unvaccinated patients. We present a case of a 43-year-old male who underwent bilateral sequential lung transplantation for pulmonary alveolar microlithiasis (PAM) and had an uneventful recovery. However, two years post-transplantation, the patient developed chronic lung allograft dysfunction (CLAD) with bronchiolitis obliterans syndrome and two episodes of COVID-19 infection...
April 2024: Journal of Surgical Case Reports
https://read.qxmd.com/read/38582877/a-placebo-controlled-crossover-trial-to-investigate-the-efficacy-of-tiotropium-bromide-or-placebo-added-to-usual-care-in-stable-symptomatic-post-hematopoietic-stem-cell-transplantation-hsct-bronchiolitis-obliterans-syndrome-bos
#2
JOURNAL ARTICLE
Naeemeh Dini, Amin Pastaki Khoshbin, Rasoul Aliannejad, Hooman Bakhshandeh, Katayoun Najafizadeh, Mahshid Mehdizadeh, Shahideh Amini
BACKGROUND: Despite the fundamental progress in hematopoietic stem cell transplant, this treatment is also associated with complications. Graft-versus-host disease is a possible complication of HSCT. Bronchiolitis obliterans syndrome (BOS) is the pulmonary form of this syndrome. Due to the high morbidity and mortality rate of BOS, various studies have been conducted in the field of drug therapy for this syndrome, although no standard treatment has yet been proposed. According to the hypotheses about the similarities between BOS and chronic obstructive pulmonary disease, the idea of using tiotropium bromide as a bronchodilator has been proposed...
April 6, 2024: Trials
https://read.qxmd.com/read/38508486/ex-vivo-lung-perfusion-in-donation-after-circulatory-death-a-post-hoc-analysis-of-the-novel-trial
#3
JOURNAL ARTICLE
Doug A Gouchoe, Pablo G Sanchez, Jonathan D'Cunha, Christian A Bermudez, Mani A Daneshmand, Robert D Davis, Matthew G Hartwig, Thomas C Wozniak, Zachary N Kon, Bartley P Griffith, William R Lynch, Tiago N Machuca, Michael J Weyant, Michael E Jessen, Michael S Mulligan, Frank D'Ovidio, Phillip C Camp, Edward Cantu, Bryan A Whitson
OBJECTIVE: Donation after circulatory death (DCD) donors offer the ability to expand the lung donor pool and ex vivo lung perfusion (EVLP) further contributes to this ability by allowing for additional evaluation and resuscitation of these extended criteria donors. We sought to determine the outcomes of recipients receiving organs from DCD EVLP donors in a multi-center setting. METHODS: This was an unplanned post-hoc analysis of a multicenter, prospective, non-randomized trial that took place in 2011-2017 with 3-years of follow up...
March 18, 2024: Journal of Thoracic and Cardiovascular Surgery
https://read.qxmd.com/read/38504551/a-review-of-the-therapeutic-potential-of-the-cysteinyl-leukotriene-antagonist-montelukast-in-the-treatment-of-bronchiolitis-obliterans-syndrome-following-lung-and-hematopoietic-stem-cell-transplantation-and-its-possible-mechanisms
#4
REVIEW
Nastaran Kordjazy, Shahideh Amini
Lung and hematopoietic stem cell transplantation are therapeutic modalities in chronic pulmonary and hematological diseases, respectively. One of the complications in these patients is the development of bronchiolitis obliterans syndrome (BOS). The efficacy and safety of available treatment strategies in BOS remain a challenge. A few mechanisms have been recognized for BOS in lung transplant and graft- versus -host disease (GVHD) patients involving the TH-1 and TH-2 cells, NF-kappa B, TGF-b, several cytokines and chemokines, and cysteinyl leukotrienes (CysLT)...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38485149/ers-ebmt-clinical-practice-guideline-on-treatment-of-pulmonary-chronic-graft-versus-host-disease-in-adults
#5
JOURNAL ARTICLE
Saskia Bos, John Murray, Monia Marchetti, Guang-Shing Cheng, Anne Bergeron, Daniel Wolff, Clare Sander, Akshay Sharma, Sherif M Badawy, Zinaida Peric, Agnieszka Piekarska, Joseph Pidala, Kavita Raj, Olaf Penack, Samar Kulkarni, Molly Beestrum, Andrea Linke, Matthew Rutter, Courtney Coleman, Thomy Tonia, Hélène Schoemans, Daiana Stolz, Robin Vos
Chronic graft- versus -host disease (cGvHD) is a common complication after allogeneic haematopoietic stem cell transplantation, characterised by a broad disease spectrum that can affect virtually any organ. Although pulmonary cGvHD is a less common manifestation, it is of great concern due to its severity and poor prognosis. Optimal management of patients with pulmonary cGvHD is complicated and no standardised approach is available.The purpose of this joint European Respiratory Society and European Society for Blood and Marrow Transplantation Task Force was to develop evidence-based recommendations regarding the treatment of pulmonary cGvHD phenotype bronchiolitis obliterans syndrome in adults...
March 14, 2024: European Respiratory Journal
https://read.qxmd.com/read/38482465/autoreactive-antibodies-associated-with-castleman-disease-triad
#6
Jacqueline A Turner, Ali Hakimi, Hannah Lee, Jeffrey T Schowinsky, Jeffrey M Sippel, Bradford J Siegele, Raul M Torres, William A Robinson
The Castleman triad has been described in a select few patients presenting with a retroperitoneal mass, mucocutaneous pemphigus vulgaris, and bronchiolitis obliterans. Here, we describe the Castleman triad in a 19-year-old male with unicentric hyaline vascular type Castleman disease (HV-CD). This patient presented with an array of positive antibodies, including anti-cyclic citrullinated peptide, anti-double-stranded DNA, and Sjogren's IgG. Interestingly, the patient's rheumatologic symptoms resolved after tumor resection, while his antibody profile remained relatively unchanged...
2024: Case Reports in Immunology
https://read.qxmd.com/read/38469429/hlh-syndrome-in-a-community-hospital-the-challenge-of-an-early-diagnosis
#7
JOURNAL ARTICLE
Yuval Wagner, Dganit Adam, Galit Pomeranz Engelberg, Avishalom Pomeranz, Yoav H Messinger
INTRODUCTION: Hemophagocytic lymphohistiocytosis (HLH) is a potentially fatal hyperinflammatory cytokine storm. It can be secondary to infections, malignancies, autoimmune diseases, or the manifestation of genetic disorders, including primary immune deficiency. HLH requires a high index of suspicion and is challenging for community hospitals. METHODS: Medical records of children with HLH admitted to the Meir Medical Center in Israel between 2014 and 2017 were reviewed...
2024: Pediatric Health, Medicine and Therapeutics
https://read.qxmd.com/read/38454132/late-onset-pulmonary-complications-following-allogeneic-hematopoietic-cell-transplantation-in-pediatric-patients-a-prospective-multicenter-study
#8
JOURNAL ARTICLE
Véronique Houdouin, Jean Christophe Dubus, Sophie Guilmin Crepon, Fanny Rialland, Bénedicte Bruno, Charlotte Jubert, Philippe Reix, Marlène Pasquet, Catherine Paillard, Dalila Adjaoud, Cyril Schweitzer, Muriel Le Bourgeois, Justine Pages, Adyla Yacoubi, Jean Hugues Dalle, Anne Bergeron, Christophe Delclaux
The primary objective of our multicenter prospective study was to describe the incidence of late-onset non-infectious pulmonary complications (LONIPCs) in children undergoing hematopoietic cell transplantation (HCT) using sensitive criteria for pulmonary function test (PFT) abnormalities including the non-specific pattern of airflow obstruction. Secondary objectives were to assess the factors associated with LONIPC occurrence and the sensitivity of the 2014 NIH-Consensus Criteria of bronchiolitis obliterans syndrome (BOS)...
March 7, 2024: Bone Marrow Transplantation
https://read.qxmd.com/read/38438967/application-of-metagenomic-next-generation-sequencing-in-the-clinical-diagnosis-of-infectious-diseases-after-allo-hsct-a-single-center-analysis
#9
JOURNAL ARTICLE
Hailong Yuan, Xiaolu Ma, Jianli Xu, Peng Han, Guanhua Rao, Gang Chen, Kaile Zhang, Ruixue Yang, Chuixia Han, Ming Jiang
BACKGROUND: We investigated the value of metagenomic next-generation sequencing (mNGS) in diagnosing infectious diseases in patients receiving allogeneic hematopoietic stem cell transplantation (allo-HSCT). METHODS: Fifty-four patients who had fever following allo-HSCT from October 2019 to February 2022 were enrolled. Conventional microbiological tests (CMTs) and mNGS, along with imaging and clinical manifestations, were used to diagnose infection following allo-HSCT...
March 4, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38394744/ventilatory-capacity-in-clad-is-driven-by-dysfunctional-airway-structure
#10
JOURNAL ARTICLE
Pieterjan Kerckhof, Gene P L Ambrocio, Hanne Beeckmans, Janne Kaes, Vincent Geudens, Saskia Bos, Lynn Willems, Astrid Vermaut, Marie Vermant, Tinne Goos, Charlotte De Fays, Lucia Aversa, Yousry Mohamady, Arno Vanstapel, Michaela Orlitová, Jan Van Slambrouck, Xin Jin, Vimi Varghese, Iván Josipovic, Matthieu N Boone, Lieven J Dupont, Birgit Weynand, Adriana Dubbeldam, Dirk E Van Raemdonck, Laurens J Ceulemans, Ghislaine Gayan-Ramirez, Laurens J De Sadeleer, John E McDonough, Bart M Vanaudenaerde, Robin Vos
BACKGROUND: Chronic lung allograft dysfunction (CLAD) encompasses three main phenotypes: bronchiolitis obliterans syndrome (BOS), restrictive allograft syndrome (RAS) and a Mixed phenotype combining both pathologies. How the airway structure in its entirety is affected in these phenotypes is still poorly understood. METHODS: A detailed analysis of airway morphometry was applied to gain insights on the effects of airway remodelling on the distribution of alveolar ventilation in end-stage CLAD...
February 22, 2024: EBioMedicine
https://read.qxmd.com/read/38384867/restrictive-allograft-syndrome-after-covid-19-pneumonia-a-case-report
#11
Yuji Ohizumi, Ryo Kurokawa, Shiori Amemiya, Tatsuya Ito, Masaaki Sato, Osamu Abe
Chronic lung allograft dysfunction (CLAD) continues to be the leading cause of death in the long term after lung transplantation (LTx). CLAD has the following two main subtypes: bronchiolitis obliterans syndrome (BOS) and restrictive allograft syndrome (RAS). BOS features obstructive lung dysfunction, while RAS features restrictive lung dysfunction. Overall, RAS has a worse prognosis. The pathophysiology of CLAD is not fully understood; however, pulmonary infections can trigger CLAD, including coronavirus disease 2019 (COVID-19) pneumonia...
February 2024: Curēus
https://read.qxmd.com/read/38360272/detection-of-bronchiolitis-obliterans-syndrome-using-nitrogen-multiple-breath-washout-in-children-post-haemopoietic-stem-cell-transplant
#12
JOURNAL ARTICLE
Nicole Westrupp, Cassidy Du Berry, Theresa Cole, Shivanthan Shanthikumar, Liam Welsh
BACKGROUND: Bronchiolitis obliterans syndrome (BOS) is a severe complication following haemopoietic stem cell transplantation (HSCT) and is often undetected until there is significant deterioration in pulmonary function. Lung clearance index (LCI2.5 ) derived from the nitrogen multiple breath washout (N2 MBW) test may be more feasible and sensitive than spirometry, which is currently used for surveillance and detection of BOS. OBJECTIVE: We aimed to examine the feasibility of performing surveillance N2 MBW in children post-HSCT, and in an exploratory analysis, determine if LCI2...
February 13, 2024: Transplantation and cellular therapy
https://read.qxmd.com/read/38307417/association-between-cytomegalovirus-viremia-and-long-term-outcomes-in-lung-transplant-recipients
#13
JOURNAL ARTICLE
Mitsuaki Kawashima, Jin Ma, Ella Huszti, Liran Levy, Gregory Berra, Benjamin Renaud-Picard, Akihiro Takahagi, Rasheed Ghany, Masaaki Sato, Shaf Keshavjee, Lianne Singer, Shahid Husain, Deepali Kumar, Jussi Tikkanen, Tereza Martinu
Although cytomegalovirus (CMV) viremia/DNAemia has been associated with reduced survival after lung transplantation, its association with chronic lung allograft dysfunction (CLAD) and its phenotypes is unclear. We hypothesized that, in a modern era of CMV prophylaxis, CMV DNAemia would still remain associated with death, but also represent a risk factor for CLAD and specifically restrictive allograft syndrome (RAS)/mixed phenotype. This was a single-center retrospective cohort study of all consecutive adult, first, bilateral-/single-lung transplants done between 2010-2016, consisting of 668 patients...
February 1, 2024: American Journal of Transplantation
https://read.qxmd.com/read/38141895/short-term-outcomes-after-third-time-lung-transplantation-a-single-institution-experience
#14
JOURNAL ARTICLE
Vikram F Gupta, Samantha E Halpern, Arya Pontula, Madison K Krischak, John M Reynolds, Jacob A Klapper, Matthew G Hartwig, John C Haney
BACKGROUND: Reoperative lung transplantation (LTx) survival has improved over time such that a growing number of patients may present for third-time LTx (L3Tx). To understand the safety of L3Tx, we evaluated perioperative outcomes and 3-year survival after L3Tx at a high-volume US LTx center. METHODS: This retrospective study included all patients who underwent bilateral L3Tx at our institution. Using an optimal matching technique, a primary LTx (L1Tx) cohort was matched 1:2 and a second-time LTx (L2Tx) cohort 1:1...
December 21, 2023: Journal of Heart and Lung Transplantation
https://read.qxmd.com/read/38087715/a-personalized-organ-based-approach-to-the-treatment-of-chronic-steroid-refractory-graft-versus-host-disease
#15
REVIEW
Hanaa Fatoum, Robert Zeiser, Shahrukh K Hashmi
Chronic graft-versus-host-disease (cGvHD) remains the leading cause of morbidity among transplant recipients. The efficacy of second-line treatments varies widely based on many factors, including wide differences in the organ overall response-rate response and in the current era where multiple agents are approved, and optimal sequencing of drugs based on organ ORR is unknown. We aimed to evaluate outcomes based on ORRs to the most common agents for the treatment of steroid-refractory/steroid-dependent cGvHD by conducting a systematic literature review...
January 2024: Blood Reviews
https://read.qxmd.com/read/38082917/global-and-regional-lung-function-assessment-using-portable-electrical-impedance-tomography-eit-system-clinical-study
#16
JOURNAL ARTICLE
Fedi Zouari, Pak To Cheung, Adrien Touboul, Wang C Kwok, Venice Sin, Eddie C Wong, Iris Y Zhou, Terence C C Tam, Russell W Chan
Recent development of affordable, portable and self-administrable electrical impedance tomography (EIT) system demonstrated the feasibility of using standalone EIT and subject's anthropometrics to predict the gold standard spirometry indicators for lung-function assessment. Compared to spirometry, the system showed the advantage of providing spatial mapping of the spirometry indicators. Nevertheless, the previous study was limited to healthy subjects. Here, we recruited (N=88): 47 lung disease patients and 41 healthy controls to perform simultaneous EIT and spirometry measurements to validate the capabilities of the system...
July 2023: Annual International Conference of the IEEE Engineering in Medicine and Biology Society
https://read.qxmd.com/read/38044496/impulse-oscillometry-versus-spirometry-to-detect-bronchiolitis-obliterans-syndrome-in-bilateral-lung-transplant-recipients-a-prospective-diagnostic-study
#17
JOURNAL ARTICLE
Thomas D Crowhurst, Jessica A Butler, Lauren A Bussell, Sonya D Johnston, David Yeung, Greg Hodge, Greg I Snell, Aeneas Yeo, Mark Holmes, Chien-Li Holmes-Liew
BACKGROUND: Chronic lung allograft dysfunction (CLAD), and especially bronchiolitis obliterans syndrome (BOS), remain dominant causes of morbidity and mortality after lung transplantation. Interest is growing in the forced oscillation technique, of which impulse oscillometry (IOS) is a form, as a tool to improve our understanding of these disorders. However, data remain limited and no longitudinal studies have been published, meaning there is no information regarding any capacity IOS may have for the early detection of CLAD...
December 4, 2023: Transplantation
https://read.qxmd.com/read/38012449/clinical-risk-factors-and-prognostic-model-for-patients-with-bronchiolitis-obliterans-syndrome-after-hematopoietic-stem-cell-transplantation
#18
JOURNAL ARTICLE
Qiu-Sha Huang, Tian-Xiao Han, Qi Chen, Jin Wu, Peng Zhao, Ye-Jun Wu, Yun He, Xiao-Lu Zhu, Hai-Xia Fu, Feng-Rong Wang, Yuan-Yuan Zhang, Xiao-Dong Mo, Wei Han, Chen-Hua Yan, Jing-Zhi Wang, Huan Chen, Yu-Hong Chen, Ting-Ting Han, Meng Lv, Yao Chen, Yu Wang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang, Xiao-Hui Zhang
Bronchiolitis obliterans syndrome (BOS) is a common and potentially devastating noninfectious pulmonary complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Currently, predictive tools for BOS are not available. We aimed to identify the clinical risk factors and establish a prognostic model for BOS in patients who undergo allo-HSCT. We retrospectively identified a cohort comprising 195 BOS patients from 6100 consecutive patients who were allografted between 2008 and 2022. The entire cohort was divided into a derivation cohort and a validation cohort based on the time of transplantation...
February 2024: Bone Marrow Transplantation
https://read.qxmd.com/read/37976074/defilipp-z-kim-ht-yang-z-et%C3%A2-al-clinical-response-to-belumosudil-in-bronchiolitis-obliterans-syndrome-a-combined-analysis-from-2-prospective-trials-blood-adv-2022-6-24-6263-6270
#19
JOURNAL ARTICLE
https://read.qxmd.com/read/37936997/bronchiolitis-obliterans-with-recurrent-pneumothorax-after-allogeneic-bone-marrow-transplantation
#20
Masayuki Akatsuka, Naoya Yama
Bronchiolitis obliterans syndrome (BOS) is a non-infectious pulmonary complication that can occur in patients who have undergone allogeneic bone marrow transplantation (BMT). BOS is characterized by the irreversible narrowing and obstruction of bronchi, resulting in severe respiratory distress and poor outcomes. This case report focuses on the complex management of a patient with a multifaceted medical history. A 20-year-old man was initially diagnosed with precursor B lymphoblastic lymphoma and subsequently underwent allogeneic BMT...
October 2023: Curēus
keyword
keyword
22096
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.